首页> 中文期刊> 《白求恩军医学院学报》 >银杏酮酯滴丸对不稳定型心绞痛患者临床症状和血清 hs-CRP 含量的影响

银杏酮酯滴丸对不稳定型心绞痛患者临床症状和血清 hs-CRP 含量的影响

             

摘要

Objective To investigate the effect of Ginkgo biloba extract dripping pill on clinical symptoms,and serum high sensitivity C reactive protein (hs-CRP)of patients with unstable angina pectoris.Methods Two hundred patients with unstable angina pectoris were randomly divided into control group and the observation group,100 cases in either group.Patients in both groups were treated with conventional therapy.In addition,Ginkgo biloba extract dripping pill was given orally to patients of observation group.Clin-ical symptoms and serum hs-CRP were observed before and after treatment in the two groups.Results After treatment,angina pectoris attack frequency serum hs-CRP and angina pectoris attack duration in both groups were lower than those before treatment (P <0.01), and those of the observation group were significantly lower than those of the control group (P <0.01).Level of hs-CRP in observation group was significantly lower than that in control group (P <0.01).Conclusion The clinical symptoms and laboratory indexes of pa-tients with unstable angina pectoris can be significantly improved by Ginkgo biloba extract.%目的:探讨银杏酮酯滴丸对不稳定型心绞痛患者临床症状和血清高敏 C 反应蛋白(hs-CRP)含量的影响。方法选取不稳定型心绞痛患者200例,随机分为对照组与观察组,各100例。两组均给予单硝酸异山梨酯等常规治疗,观察组在以上用药基础上加用银杏酮酯滴丸口服,观察两组治疗前后临床症状、血清 hs-CRP 变化。结果治疗后两组每日心绞痛发作次数、心绞痛发作持续时间均较治疗前下降(P <0.01),观察组较对照组下降更为明显(P <0.01),观察组心绞痛发作时硝酸甘油周用量低于对照组(P <0.01);治疗后两组 hs-CRP 均较治疗前下降(P <0.01),观察组较对照组下降更为明显(P <0.01)。结论银杏酮酯滴丸可明显改善不稳定型心绞痛患者临床症状,降低血清 hs-CRP 含量,抑制炎症反应。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号